Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Hematology/Oncology and Stem Cell Therapy|June 26, 2021
Recurrence Score Testing Does not Appear to Benefit Patients With Grade 1, Progesterone Receptor-Positive Breast Cancers: An Opportunity to Eliminate Overtreatment and Decrease Testing CostsUdai S Sibia, Thomas J Sanders, Charles Mylander, et al.
Hematology/Oncology and Stem Cell Therapy|June 26, 2023
OncotypeDX Testing Does Not Benefit Patients with Estrogen and Progesterone Receptor Positive Grade 1 Breast Cancers: A TAILORx Validated StudyUdai S Sibia, Charles Mylander, Tasha Martin, et al.
Pageof 1